Critical Care Medicine′s Development and its Effects on Cardiothoracic Surgical Care: A Review

Bentley Nicolas^*
*Correspondence: Bentley Nicolas, Department of Nursing, University of Turku, 20500 Turku, Finland, Email:

Keywords

Coronary artery by-pass graft surgery • Lung resection surgery • Aortic aneurysm

Introduction

Heart valve replacement or repair, often known as heart valve surgery, is done to fix or swap out unhealthy or damaged heart valves. This can lessen symptoms like weariness and shortness of breath by improving the blood flow through the heart. An aortic aneurysm is a bulging in the wall of the aorta, the biggest artery in the body. Aortic aneurysms can rupture and result in life-threatening hemorrhage if left untreated. In order to prevent rupture, the weakened portion of the aorta is replaced during aortic aneurysm surgery with a synthetic graft. Surgery to remove the lung, In order to remove a piece of the lung afflicted by cancer or another condition, lung resection surgery is performed. The quality of life and total lung function are subsequently enhanced by the improved ability of the residual lung tissue to function. Clinicians have particular difficulties while caring for severely sick patients who have had cardiothoracic surgery. These difficulties include:

Hemodynamic instability: Following cardiothoracic surgery, patients are frequently hemodynamically unstable, which means that their vital signs, such as blood pressure and heart rate, may change quickly. Multiple variables, including hemorrhage, fluid movements and modifications in cardiac function, can contribute to this instability. To avoid consequences like organ failure or death, clinicians must be able to immediately recognize and correct hemodynamic instability. Mechanical ventilation is a common requirement for individuals who have had cardiothoracic surgery and entails using a machine to support breathing. Because individuals' levels of lung function may fluctuate and their needs for assistance may alter, managing mechanical ventilation can be difficult. To improve patient outcomes, clinicians must be adept at modifying mechanical ventilation settings.

Effective pain management is crucial for the comfort and rehabilitation of patients after cardiothoracic surgery since it can be uncomfortable. To balance the risk of problems with pain alleviation, practitioners must be proficient in regulating the adverse effects of various pain drugs, such as respiratory depression. Coagulation Management: Due to the increased risk of bleeding in patients who have undergone cardiothoracic surgery, doctors must be skilled at managing coagulation (clotting) in order to minimize bleeding problems while reducing the risk of thromboembolism (blood clots) [1,2].

Literature Review

Role of cardiothoracic surgical critical care medicine in patients

The management of patients who have had cardiothoracic surgery or who are critically sick with cardiothoracic diseases depends heavily on cardiothoracic surgical critical care medicine. Some of the ways that cardiothoracic surgical critical care medicine benefits patient care are listed below:

Postoperative management: Following cardiothoracic surgery, patients are under the care of cardiothoracic surgical critical care medicine experts. They keep a careful eye on patients for complications including bleeding, infection and organ malfunction and respond quickly to address any problems that develop. Additionally, they oversee diet, pain management and other aspects of rehabilitation.

Mechanical ventilation: Cardiothoracic surgery patients frequently need artificial ventilation to assist their breathing. Specialists in cardiothoracic surgery and critical care medicine are adept in managing mechanical ventilation, which includes modifying ventilator settings, checking oxygen and carbon dioxide levels and weaning patients off the ventilator as soon as it's safe to do so.

Hemodynamic management: Hemodynamic instability, a frequent complication following cardiothoracic surgery, is managed by specialists in critical care medicine for cardiothoracic surgery. They continuously monitor their patients' heart rate, blood pressure and other vital indicators and employ a number of therapies to keep the blood flow to their important organs steady.

Continuous Renal Replacement Therapy (CRRT): CRRT may be used by experts in cardiothoracic surgery and critical care medicine to support patients' renal function in the ICU. For severely sick patients who are unable to endure intermittent dialysis, CRRT is a kind of dialysis that can be carried out continuously for a period of several days.

Extracorporeal Membrane Oxygenation (ECMO): To assist patients' heart and lung function, cardiothoracic surgical critical care medicine professionals may employ ECMO. With ECMO, a patient's blood is pumped and oxygenated outside of the body, freeing up their heart and lungs to rest and heal [3-6].

The management of patients who have had cardiothoracic surgery or who are critically sick with cardiothoracic diseases depends heavily on cardiothoracic surgical critical care medicine. It calls for a distinct skill set and a profound comprehension of the particular difficulties and complexity of these individuals.

Discussion

Emergence of critical care medicine and effect on cardiothoracic surgical care

Cardiothoracic surgical treatment has been significantly impacted by the development of critical care medicine. The management of critically sick patients who require intensive monitoring, support and therapy is the emphasis of the profession of critical care medicine. Previously, patients having cardiothoracic surgery were treated in a regular surgical ward or an Intensive Care Unit (ICU) that was not expressly created to cater to the special requirements of cardiothoracic surgical patients. However, the results of cardiothoracic surgery have greatly improved with the introduction of specialist cardiothoracic ICUs and the growing use of specialized monitoring and treatment techniques. The capacity to closely monitor patients and spot early warning signals of problems is one of critical care medicine's most significant benefits on cardiothoracic surgery treatment.

For instance, cardiothoracic Intensive Care Units (ICUs) include specialist monitors that can track a patient's heart rate, blood pressure and oxygen saturation constantly. This makes it possible for medical professionals to identify early indications of hemodynamic instability or respiratory distress, which can help avoid major problems. The capacity to administer enhanced life support techniques has a significant impact on cardiothoracic surgical treatment. For instance, patients undergoing cardiothoracic surgery can need extracorporeal membrane oxygenation (ECMO), inotropic assistance, or mechanical breathing. Specialized critical care teams with the necessary training can deliver these advanced life support techniques in a cardiothoracic ICU.

Conclusion

Finally, the postoperative recovery of patients who have had cardiothoracic surgery has also been significantly impacted by critical care medicine. Healthcare professionals can enhance the patient's recovery by regularly monitoring patients in the ICU and making any necessary adjustments to drugs and other therapies. In order to aid patients in recovering more quickly and with fewer consequences, trained critical care teams can offer multidisciplinary treatment that includes pain management, dietary assistance and physical therapy. In conclusion, the development of critical care medicine has greatly influenced cardiothoracic surgical treatment by enabling tighter monitoring, more sophisticated life support techniques and specialized multidisciplinary care. These developments have helped patients who undergo cardiothoracic surgery achieve better results and a higher quality of life.

Acknowledgement

None.

Conflict of Interest

No conflict of interest.

References

1. Costerton, J. William, Philip S. Stewart and E. Peter Greenberg. "Bacterial biofilms: A common cause of persistent infections." Sci 284 (1999): 1318-1322.

Google Scholar, Crossref, Indexed at

2. Yan, Zisui, Michelle Huang, Christian Melander and Birthe V. Kjellerup, et al. "Dispersal and inhibition of biofilms associated with infections." J Appl Microbiol 128 (2020): 1279-1288.

Google Scholar, Crossref, Indexed at

3. Tran, Hoai My, Hien Tran, Marsilea A. Booth and Kate E. Fox, et al. "Nanomaterials for treating bacterial biofilms on implantable medical devices." Nanomater 10 (2020): 2253.

Google Scholar, Crossref, Indexed at

4. Rosman, Colin WK, Jan Maarten Van Dijl and Jelmer Sjollema. "Interactions between the foreign body reaction and S. aureus biomaterial-associated infection. Winning strategies in the derby on biomaterial implant surfaces." Crit Rev Microbiol 48 (2022): 624-640.

Google Scholar, Crossref, Indexed at

5. Luo, Ying, Qianqian Yang, Dan Zhang and Wei Yan, et al. "Mechanisms and control strategies of antibiotic resistance in pathological biofilms." (2021): 1-7.

Google Scholar, Crossref, Indexed at

6. Mishra, Sonal, Amit Gupta, Vijay Upadhye and Suresh C. Singh, et al. "Therapeutic strategies against biofilm infections." Life 13 (2023): 172.

Google Scholar, Crossref, Indexed at